The Patent Finder

Taligen Therapeutics, Inc.

Also on record
Records under this name other than patents Taligen Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 3 of 3 · Back to Taligen Therapeutics, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 9,096,677Humaneered Anti-Factor B Antibody
Formerly held
In force
 · High confidence
In forceHigh confidence
US 7,964,705Humaneered Anti-Factor B Antibody
Formerly held
In force
 · High confidence
In forceHigh confidence
US 10,239,937Treatment of Paroxysmal Nocturnal Hemoglobinuria, Hemolytic Anemias and Disease States Involving Intravascular and Extravascular Hemolysis
Formerly held
Lapsed on the fee record
Ended Mar 26, 2023 · High confidence
Lapsed on the fee recordEnded Mar 26, 2023High confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited